The function of type I interferons in antimicrobial immunity

Current Opinion in Immunology

Volumn 12, Issue 4, 2000, Pages 419-424

  Bogdan, Christian ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; NITRIC OXIDE;

ANTIVIRAL ACTIVITY; CYTOKINE PRODUCTION; DENDRITIC CELL; HELPER CELL; IMMUNE RESPONSE; INFECTION; MACROPHAGE; NATURAL KILLER CELL; REVIEW; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0034044735     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(00)00111-4     Document Type: Review

References (94)

1. Roberts R.M., Liu L., Guo Q., Leaman D., Bixby J. The evolution of the type I interferons. J Interferon Cytokine Res. 18:1998;805-816.
2. Nathan C. Interferon and inflammation. Gallin J.I., Goldstein I.M., Snyderman R. Inflammation: basic principles and clinical correlates. 1992;265-290 Raven Press, Ltd, New York.
3. Lefevre F., Guillomot M., D′Andrea S., Battegay S., La Bonnardiere C. Interferon-delta: the first member of a novel type I interferon family. Biochimie. 80:1998;779-788.
4. Horton H.M., Hernandez P., Parker S.E., Barnhart K.M. Antitumor effects of interferon-omega: in vivo therapy of human tumor xenografts in nude mice. Cancer Res. 59:1999;4064-4068.
5. Alexenko A.P., Leaman D.W., Li J., Roberts R.M. The antiproliferative and antiviral activities of IFN-tau variants in human cells. J Interferon Cytokine Res. 17:1997;769-779.
6. Gresser I. Wherefore interferon? J Leukoc Biol. 61:1997;567-574.
7. Müller U., Steinhoff U., Reis L.F.L., Hemmi S., Pavlovic J., Zinkernagel R.M., Aguet M. Functional role of type I and type II interferons in antiviral defense. Science. 264:1994;1918-1921.
8. Hwang S.Y., Hertzog P.J., Holland K.A., Sumarsono S.H., Tymms M.J., Hamilton J.A., Whitty G., Beroncello I., Kola I. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc Natl Acad Sci USA. 92:1995;11284-11288.
9. Meraz M.A., White J.M., Sheehan K.C.F., Bach E.A., Rodig S.J., Dighe A.S., Kaplan D.H., Riley J.K., Greenlund A.C., Campbell D.et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the Jak-STAT signaling pathway. Cell. 84:1996;431-442.
10. Durbin J.E., Hackenmüller R., Simon M.C., Levy D.E. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell. 84:1996;443-450.
11. Rodig S.J., Meraz M.A., White J.M., Lampe P.A., Riley J.K., Arthur C.D., King K.L., Sheehan K.C.F., Yin L., Pennica D.et al. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell. 93:1998;373-383.
12. Kimura T., Nakayama K., Penninger J., Kitagawa M., Harada H., Matsuyama T., Tanaka N., Kamijo R., Vilcek J., Mak T.W., Taniguchi T. Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science. 264:1994;1921-1924.
13. Mogensen K.E., Lewerenz M., Reboul J., Lutfalla G., Uze G. The type I interferon receptor: structure, function and evolution of a family business. J Interferon Cytokine Res. 19:1999;1069-1098.
14. Sen G.C., Ransohoff R.M. Interferon-induced antiviral actions and their regulation. Adv Virus Res. 42:1993;57-102.
15. Hefti H.P., Frese M., Landis H., Di Paolo C., Aguzzi A., Haller O., Pavlovic J. Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections. J Virol. 73:1999;6984-6991.
16. van den Broek M.F., Müller U., Huang S., Zinkernagel R.M., Aguet M. Immune defence in mice lacking type I and/or type II interferon receptors. Immunol Rev. 148:1995;5-18.
17. Belardelli F., Gresser I. The neglected role of type I interferon in the T cell response: implications for its clinical use. Immunol Today. 17:1996;369-372.
18. Nickolaus P., Zawatzky R. Inhibition by interleukin-4 of constitutive beta interferon synthesis in mouse macrophages. J Virol. 68:1994;6763-6766.
19. Fultz M.J., Vogel S.N. Autoregulation by interferons provides an endogenous 'priming' signal for LPS-responsive macrophages. J Endotoxin Res. 2:1995;77-84.
20. Nakane A., Minagawa T. Alternative induction of IFN-α and IFN-γ by Listeria monocytogenes. J Immunol. 126:1981;2139-2142.
21. Roman M., Martin-Orozco E., Goodman J.S., Nguyen M.-.D., Sato Y., Ronaghy A., Kornbluth R.S., Richman D.D., Carson D.A., Raz E. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med. 3:1997;849-854.
22. Rödel J., Groh A., Vogelsang H., Lehmann M., Hartmann M., Straube E. Beta interferon is produced by Chlamydia trachomatis-infected fibroblast-like synoviocytes and inhibits gamma interferon-induced HLA-DR expression. Infect Immun. 66:1998;4491-4495.
23. Diefenbach A., Schindler H., Donhauser N., Lorenz E., Laskay T., MacMicking J., Röllinghoff M., Gresser I., Bogdan C. Type 1 interferon (IFN-α/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity. 8:1998;77-87.
24. Sing A., Merlin T., Knopf H-P., Nielsen P.J., Loppnow H., Galanos C., Freudenberg M.A. Bacterial induction of beta interferon in mice is a function of the lipopolysaccharide component. Infect Immun. 68:2000;1600-1607. This paper identifies LPS from Gram-negative bacteria as the only bacterial component that is capable of inducing IFN-β in significant amounts in mouse macrophages in vitro and in vivo. All Gram-positive bacteria tested were inactive in this respect.
25. Eloranta M.L., Sandberg K., Ricciardi-Castagnoli P., Lindahl M., Alm G.V. Production of interferon alpha/beta by murine dendritic cell lines stimulated by virus and bacteria. Scand J Immunol. 46:1997;235-241.
26. Svenson H., Johannison A., Nikkila T., Alm G.V., Cederblad B. The cell surface phenotype of human natural interferon-alpha producing cells as determined by flow cytometry. Scand J Immunol. 44:1996;164-172.
27. +) thus confirming and extending earlier findings by Svenson et al. [26]. Mature type-2 dendritic cells are thought to support the development of Th2 cells.
28. -) in the blood, which forms a subset of dendritic cell (DC) precursors, corresponds to the previously described plasmacytoid monocytes (PMs) that are found in lymphoid tissues. These peripheral PM/DC precursors released high amounts of IFN-α/β upon culture with IL-3 and either stimulation with cells transfected with CD40 ligand or stimulation with viruses. These cells induced IL-4-producing T cells as well as IFN-γ-producing T cells; no evidence for a preferential induction of Th2 cells was obtained.
29. Payvandi F., Amrute S., Fitzgerald-Bocarsly P. Exogenous and endogenous IL-10 regulate IFN-α production by peripheral blood mononuclear cells in response to viral stimulation. J Immunol. 160:1998;5861-5868.
30. Tebo J.M., Kim H.S., Gao J., Armstrong D.A., Hamilton T.A. Interleukin-10 suppresses IP-10 gene transcription by inhibiting the production of class I interferon. Blood. 92:1998;4742-4749.
31. Guillemard E., Varano B., Belardelli F., Quero A.M., Gessani S. Inhibitory activity of constitutive nitric oxide on the expression of alpha/beta interferon genes in murine peritoneal macrophages. J Virol. 73:1999;7328-7333. This is the first study to demonstrate that NO regulates the production of IFN-α/β by macrophages. IFN-α/β thus joins the already extensive list of cytokines that are controlled by NOS2-derived NO (reviewed in [36]).
32. Paquette R.L., Hsu N.C., Kiertscher S.M., Park A.N., Tran L., Roth M.D., Glaspy J.A. Interferon-α and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells. J Leukoc Biol. 64:1998;358-367.
33. Taylor J.L., Grossberg S.E. The effects of interferon-alpha on the production and action of other cytokines. Semin Oncol. 25:1998;23-29.
34. Ralph P., Nakoinz I., Rennick D. Role of interleukin-2, interleukin-4, and alpha/beta and gamma interferon in stimulating macrophage antibody-dependent tumoricidal activity. J Exp Med. 167:1988;712-717.
35. Sampson L.L., Heuser J., Brown E.J. Cytokine regulation of complement receptor-mediated ingestion by mouse peritoneal macrophages. M-CSF and IL-4 activate phagocytosis by a common mechanism requiring autostimulation by IFN-β J Immunol. 146:1991;1005-1013.
36. Bogdan C., Röllinghoff M., Diefenbach A. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol. 12:2000;64-76.
37. Gao J.J., Filla M.B., Fultz M.J., Vogel S.N., Russell S.W., Murphy W.J. Autocrine/paracrine IFN-α/β mediates the lipopolysaccharide-induced activation of transcription factor Stat1α in mouse macrophages: pivotal role of Stat1α in induction of the inducible nitric oxide synthase gene. J Immunol. 161:1998;4803-4810.
38. Katayama Y. Human receptor for measles virus (CD46) enhances nitric oxide production and restricts virus replication in mouse macrophages by modulating production of alpha/beta interferon. J Virol. 74:2000;1252-1257.
39. Lopez-Collazo E., Hortelano S., Rojas A., Bosca L. Triggering of peritoneal macrophages with IFN-α/β attenuates the expression of inducible nitric oxide through a decrease in NF-κB activation. J Immunol. 160:1998;2889-2895.
40. Mattner J., Schindler H., Diefenbach A., Röllinghoff M., Gresser I., Bogdan C. Regulation of type 2 NO synthase by type I interferons in macrophages infected with Leishmania major. Eur J Immunol. 30:2000;. in press.
41. Hunter C.A., Gabriel K.E., Radzanowski T., Neyer L.E., Remington J.S. Type I interferons enhance production of IFN-gamma by NK cells. Immunol Lett. 59:1997;1-5.
42. Rogge L., Barberis-Maino L., Biffi M., Passini N., Presky D.H., Gubler U., Sinigaglia F. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med. 185:1997;825-831.
43. Szabo S.J., Dighe A.S., Gubler U., Murphy K.M. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med. 185:1997;817-824.
44. Rogge L., D'Ambrosio D., Biffi M., Penna G., Minetti L.J., Presky D.H., Adorini L., Sinigaglia F. The role of Stat4 in species-specific regulation of Th cell development by type 1 interferons. J Immunol. 161:1998;6567-6574.
45. Brinkmann V., Geiger T., Alkan S., Heusser C.H. Interferon α increases the frequency of interferon γ-producing human CD4+ T cells. J Exp Med. 178:1993;1655-1663.
46. Parronchi P., Mohapatra S., Sampognaro S., Giannarini L., Wahn U., Chong P., Mohapatra S., Maggi E., Renz H., Romagnani S. Effects of interferon-α on cytokine profile, T cell receptor repertoire and peptide reactivity of human allergen-specific T cells. Eur J Immunol. 26:1996;697-703.
47. Wenner C.A., Güler M.L., Macatonia S.E., O'Garra A., Murphy K.M. Roles of IFN-γ and IFN-α in IL-12 induced T-helper cell-1 development. J Immunol. 156:1996;1442-1447.
48. Yaegashi Y., Nielsen P., Sing A., Galanos C., Freudenberg M.A. Interferon β, a cofactor in the interferon γ production induced by gram-negative bacteria. J Exp Med. 181:1995;953-960.
49. Vieillard V., Cremer I., Lauret E., Rozenbaum W., Debre P., Autran B., de Maeyer E. Interferon-β transduction of peripheral blood lymphocytes from HIV-infected donors increases Th1-type cytokine production and improves the proliferative response to recall antigens. Proc Natl Acad Sci USA. 94:1997;11595-11600.
50. Sareneva T., Matikainen S., Kurimoto M., Julkunen I. Influenza A virus-induced IFN-α/β and IL-18 synergistically enhance IFN-γ gene expression in human T cells. J Immunol. 160:1998;6032-6038.
51. Cousens L.P., Orange J.S., Su H.C., Biron C.A. Interferon-α/β inhibition of interleukin-12 and interferon-γ production in vitro and endogenously during viral infection. Proc Natl Acad Sci USA. 94:1997;634-639.
52. McRae B.L., Beilfuss B.A., van Seventer G.A. IFN-β differentially regulates CD40-induced cytokine secretion by human dendritic cells. J Immunol. 164:2000;23-28. The authors previously demonstrated that, in a T-cell/dendritic-cell coculture system, IFN-α/β inhibits the production of IL-12 by DCs and the development of Th1 cells. The authors now provide evidence that IFN-α/β interferes with a stimulatory signal elicited by cross-linking of CD40.
53. Zagury D., Lachgar A., Chams V., Fall L.S., Bernard J., Zagury J-F., Bizzini B., Gringeri A., Santagostino E., Rappaport J.et al. Interferon-α and tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci USA. 95:1998;3851-3856.
54. Luo Y., Chen X., Downs T.M., DeWolf W.C., O'Donnell M.A. IFN-α2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis Bacillus Calmette-Guerin immunotherapy. J Immunol. 162:1999;2399-2405.
55. Harraga S., Godot V., Bresson-Hadni S., Pater C., Beurton I., Bartholomot B., Vuitton D.A. Clinical efficacy of and switch from T helper 2 to T helper 1 cytokine profile after interferon α2a monotherapy for human echinococcosis. Clin Infect Dis. 29:1999;206-207.
56. •].
57. •] define a novel, antiapoptotic effect of IFN-α/β on T cells. The survival signal delivered by IFN-α/β appears to be distinct from its ability to modulate T cell growth (see [58-60]).
58. Tough D.F., Borrow P., Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science. 272:1996;1947-1950.
59. Sun S., Zhang X., Tough D.F., Sprent J. Type I interferon-mediated stimulation of T cells by CpG DNA. J Exp Med. 188:1998;2335-2342.
60. Petricoin E.F., Ito S., Williams B.L., Audet S., Stancato L.F., Gamero A., Clouse K., Grimley P., Weiss A., Beeler J.et al. Antiproliferative action of interferon-α requires components of T cell-receptor signalling. Nature. 390:1997;629-632.
61. Sallusto F., Lanzavecchia A., Mackay C.R. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today. 19:1998;568-574.
62. Garcia-Sastre A., Durbin R.K., Zheng H., Palese P., Gertner R., Levy D.E., Durbin J.E. The role of interferon in influenza virus tissue tropism. J Virol. 72:1998;8550-8558.
63. Yeow W-S., Lawson C.M., Beilharz M.W. Antiviral activities of individual murine IFN-α subtypes in vivo: intramuscular injection of IFN expression constructs reduces cytomegalovirus replication. J Immunol. 160:1998;2932-2939.
64. Noisakran S., Campbell I.L., Carr D.J.J. Ectopic expression of DNA encoding IFN-α1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis. J Immunol. 162:1999;4184-4190.
65. Leib D.A., Harrison T.E., Laslo K.M., Machalek M.A., Moorman N.J., Virgin H.W. Interferons regulate the phenotype of wildtype and mutant herpes simplex viruses in vivo. J Exp Med. 189:1999;663-672.
66. Mrkic B., Odermatt B., Klein M.A., Billeter M.A., Pavlovic J., Cattaneo R. Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice. J Virol. 74:2000;1364-1372.
67. Ryman K.D., Klimstra W.B., Nguyen K.B., Biron C.A., Johnston R.E. Alpha/beta interferon protects adult mice from fatal sindbis virus infection and is an important determinant of cell and tissue tropism. J Virol. 74:2000;3366-3378. In mice lacking the type I IFN receptor a subcutaneous infection with Sindbis virus leads to rapid viral replication in cells of the macrophage/dendritic-cell lineage, in the draining lymph node (within 24 hours of infection) and in visceral organs (i.e. within 72 hours in spleen, liver, lung, thymus and kidney).
68. Deonarain R., Alcami A., Alexiou M., Dallman M.J. Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon. J Virol. 74:2000;3404-3409. This study provides direct in vivo evidence for a hierarchy amongst type I IFNs, in which IFN-β is required for the expression of IFN-α.
69. + T cell IFN-γ response is independent of IL-12 whereas in the absence of IFN-α/β functions (due to a deletion of the IFNAR-1) endogenous IL-12 constituted an alternative pathway leading to the expression of IFN-γ.
70. Guidotti L.G., McClary H., Moorhead Loudis J., Chisari F.V. Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice. J Exp Med. 191:2000;1247-1252. This is the first study to dissect the direct, NO-independent antiviral effects of IFNs from indirect, NO-dependent effects. Whereas the antiviral effect of IFN-γ is mainly mediated by the induction of NOS2, IFN-α/β is able to exert a direct, NO-independent effect on hepatitis B virus replication.
71. Erlandsson L., Blumenthal R., Eloranta M-L., Engel H., Alm G., Weiss S., Leanderson T. Interferon-β is required for interferon-α production in mouse fibroblasts. Curr Biol. 8:1998;223-226.
72. Khabar K.S.A., Al-Zoghaibi F., Al-Ahdal M.N., Murayama T., Dhalla M., Mukaida N., Taha M., Al-Sedairy S., Siddiqui Y., Kessie G., Matsushima K. The α chemokine, interleukin-8, inhibits the antiviral action of interferon-α J Exp Med. 186:1997;1077-1085.
73. Mizukoshi E., Kaneko S., Kaji K., Terasaki S., Matsushita E., Muraguchi M., Ohmoto Y., Kobayashi K. Serum levels of soluble interferon alpha/beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C. Hepatology. 30:1999;1325-1331.
74. Passwell J.H., Shor R., Shoham J. The enhancing effect of interferon-β and-γ on the killing of Leishmania tropica major in human mononuclear phagocytes in vitro. J Immunol. 136:1986;3062-3066.
75. Fujioka N., Akazawa R., Sakamoto K., Ohashi K., Kurimoto M. Potential application of human interferon-alpha in microbial infections of the oral cavity. J Interferon Cytokine Res. 15:1995;1047-1051.
76. Wilson C.B., Westall J. Activation of neonatal and adult human macrophages by alpha, beta and gamma interferon. Infect Immun. 49:1985;351-356.
77. Carlin J.M., Borden E.C., Byrne G.I. Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages. J Interferon Res. 9:1989;329-337.
78. Schmitz J.L., Carlin J.M., Borden E.C., Byrne G.I. Beta interferon inhibits Toxoplasma gondii growth in human monocyte-derived macrophages. Infect Immun. 57:1989;3254-3256.
79. Orellana M.A., Suzuki Y., Araujo F., Remington J.S. Role of beta interferon in resistance to Toxoplasma gondii infection. Infect Immun. 59:1991;3287-3290.
80. Shankar A.H., Morin P., Titus R.G. Leishmania major: differential resistance to infection in C57BL/6 (high interferon-α/β) and congenic B6.C-H-28c (low interferon-α/β) mice. Exp Parasitol. 84:1996;136-143.
81. Denis M. Recombinant murine beta interferon enhances resistance of mice to systemic Mycobacterium avium infection. Infect Immun. 59:1991;1857-1859.
82. Nathan C.F., Prendergast T.J., Wiebe M.E., Stanley E.R., Platzer E., Remold H.G., Welte K., Rubin B.Y., Murray H.W. Activation of human macrophages. Comparison of other cytokines with interferon-γ J Exp Med. 160:1984;600-605.
83. Murray H.W., Szuro-Sudol A., Wellner D., Oca M.J., Granger A.M., Libby D.M., Rothermel C.D., Rubin B.Y. Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages. Infect Immun. 57:1989;845-849.
84. Havell E.A. Listeria monocytogenes-induced interferon-γ primes the host for production of tumor necrosis factor and interferon-α/β J Infect Dis. 167:1993;1364-1371.
85. Nakane A., Minagawa T. Induction of alpha and beta interferons during the hyporeactive state of gamma interferon by Mycobacterium bovis BCG cell wall fraction in Mycobacterium bovis BCG-sensitized mice. Infect Immun. 36:1982;966-970.
86. Diez B., Galdeano A., Nicolas R., Cisterna R. Relationship between the production of interferon-alpha/beta and interferon-gamma during acute toxoplasmosis. Parasitology. 99:1989;11-15.
87. Fujiki T., Tanaka A. Antibacterial activity of recombinant mouse beta interferon. Infect Immun. 56:1988;548-551.
88. Kierszenbaum F., Sonnenfeld G. Characterization of the antiviral activity produced during Trypanosoma cruzi infection and protective effects of exogenous interferon against experimental Chagas' disease. J Parasitol. 68:1982;194-198.
89. Domanski P., Nadeau O.W., Platanias L.C., Fish E., Kellum M., Pitha P., Colamonici O.R. Differential use of the βL subunit of the type I interferon (IFN) receptor determines signaling specificity for IFN-α2 and IFN-β J Biol Chem. 273:1998;3144-3147.
90. Heim A., Stille-Seigener M., Pring-Akerblom P., Grumbach I., Brehm C., Kreuzer H., Figulla H-R. Recombinant interferons beta and gamma have a higher antiviral activity than interferon-alpha in coxsackievirus B3-infected carrier state cultures of human myocardial fibroblasts. J Interferon Cytokine Res. 16:1995;283-287.
91. Hoss-Homfeld A., Zwarthoff E.C., Zawatzky R. Cell type specific expression and regulation of murine interferon alpha and beta genes. Virology. 173:1989;539-550.
92. Marie I., Durbin J.E., Levy D.E. Differential viral induction of distinct interferon-α genes by positive feedback through interferon regulatory factor-7. EMBO J. 17:1998;6660-6669.
93. Iellem A., Colantonio L., Bhakta S., Sozzani S., Mantovani A., Sinigaglia F., D'Ambrosio D. Inhibition by IL-12 and IFN-α of I-309 and macrophage-derived chemokine production upon TCR triggering of human Th1 cells. Eur J Immunol. 30:2000;1030-1039.
94. Hajnicka V., Kocakova P., Slovak M., Labuda M., Fuchsberger N., Nuttal P.A. Inhibition of the antiviral action of interferon by tick salivary gland extract. Parasite Immunol. 22:2000;201-206.